Abnormal protein aggregation is emerging as a common theme in the pathogenesis of neurodegenerative disease. Our previous studies have shown that overexpression of untranslated light neurofilament (NF-L) RNA causes motor neuron degeneration in transgenic mice, leads to accumulation of ubiquitinated aggregates in degenerating cultured motor neurons and triggers aggregation of NF-L protein and co-aggregation of mutant SOD1 protein in neuronal cells. Here, we report that p190RhoGEF, an RNA-binding protein that binds to a destabilizing element in NF-L mRNA, is involved in aggregation of NF-L protein and is implicated in the pathogenesis of motor neuron degeneration. We show that p190RhoGEF co-aggregates with unassembled NF-L protein and that co-aggregation is associated with down-regulation of parent NF-L mRNA in neuronal cells. Co-expression of NF-M increases NF assembly and reduces RNA-triggered aggregation as well as loss of solubility of NF-L protein. siRNA-induced down-regulation of p190RhoGEF not only reduces aggregation and promotes assembly of NF-L and NF-M, but also causes reversal of aggregation and recovery of NF assembly in transfected cells. Examination of transgenic models of motor neuron disease shows that prominent aggregates of p190RhoGEF and NF-L and down-regulation of NF-L expression occur in degenerating motor neurons of mice expressing untranslated NF-L RNA or a G93A mutant SOD1 transgene. Moreover, aggregates of p190RhoGEF and NF-L appear as early pathological changes in presymptomatic G93A mutant SOD1 transgenic mice. Together, the findings indicate that p190RhoGEF is involved in aggregation of NF-L protein and support a working hypothesis that aggregation of p190RhoGEF and NF-L is an upstream event triggering neurotoxicity in motor neuron disease.
INTRODUCTION
There is a growing consensus that misfolding and aggregation of proteins are a common underlying mechanism of neurotoxicity in neurodegenerative diseases (1 -7) . Although intracellular and extracellular end products of protein aggregation are neuropathological landmarks of disease, the toxicity of protein aggregation is believed to be due to soluble intermediate forms rather than the insoluble end product inclusions that accumulate in the tissues (8 -12) . Hence, neurotoxic interactions may precede the formation of inclusions, and the presence and distribution of inclusions may not correlate with the progression and extent of disease.
Protein aggregation is also strongly implicated in the pathogenesis of motor neuron degeneration due to mutant SOD1 (13 -16) . A common feature among more than 100 different disease-causing mutations is that they destabilize SOD1 protein (17 -24) , an event that may be enhanced by oxidative damage in the cell (25) . Although there are multiple and diverse adverse effects of mutant SOD1 aggregation, much less is known about the upstream events that promote preferential aggregation of a widely expressed mutant SOD1 protein in motor neurons in spinal cord and brain. Recent studies suggest that accumulations of mutant protein may result from diminished turnover in disease-afflicted tissues (26 -28) . Impairment of the ubiquitin -proteosome system by protein aggregation (29) may contribute but does not necessarily account for the preferential involvement of motor neurons in the disease process. Instead, the triggering events may be further upstream, such as the chaperone proteins and other # The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org components that interact with and determine the structure and fate of nascent mutant SOD1 proteins, as they emerge from polysomes in motor neurons.
The light neurofilament (NF-L) subunit is a highly expressed gene product of the neuronal cytoskeleton that may be instrumental in the formation of neurotoxic aggregates in motor neuron disease. NF inclusions in motor neurons have long been recognized as common pathological features of familial and sporadic ALS (30 -33) . In presymptomatic G86R mutant SOD1 transgenic mice, the formation of NF inclusions is preceded by aggregation and accumulation of NF-L, lacking NF-M or NF-H, in perikarya and neurites of motor neurons in the lumbar spinal cord (34) . Genetic evidence of NF-L involvement in motor neuron disease is now provided by the discovery of missense mutations in NF-L, which give rise to an autosomal dominant phenotype in Charcot -Marie -Tooth (CMT) disease (35, 36) . Several disease-causing mutations disrupt NF-L assembly and lead to aggregation of NF-L in neuronal cells (37 -39) . Similar disruptions of assembly with aggregation of NF-L are reproduced by expression of mutant HSP27, a chaperone protein that causes an autosomal recessive form of distal motor neuropathy in CMT2F (40) .
In previous studies, we have identified a major destabilizing element in the proximal 3 0 -UTR of the NF-L transcript (41, 42) . Mutation of this regulatory element alters the stability of the transcript and creates a mutant NF-L transgene with potent neuropathic effects on motor neurons of transgenic mice (43) . Expression of NF-L RNA containing this regulatory element in the 3 0 -UTR of a green fluorescent protein (GFP) reporter gene gives rise to a motor neuron phenotype in transgenic mice (44) and has neuropathic effects on primary motor neurons in culture (45) . The regulatory element in the 3 0 -UTR of the NF-L transcript also triggers aggregation of NF-L and mutant SOD1 proteins in Neuro 2a cells (46) , raising the possibilities that neurotoxic protein aggregation is somehow linked to the properties of RNA in the destabilizing element or to cognate RNA-binding proteins.
In the present study, we examine the role of a cognate RNAbinding protein in RNA-triggered aggregation of NF-L protein.
We herein report that p190RhoGEF, an RNA-binding protein that binds to the destabilizing element in NF-L mRNA (47) , co-aggregates with unassembled NF-L protein and that co-aggregation of p190RhoGEF and NF-L protein is associated with loss of NF-L mRNA. We further show that similar aggregates of p190RhoGEF and NF-L and loss of NF-L expression occur in different transgenic models of motor neuron disease. The findings raise the possibility that aggregation of unassembled NF-L protein may be a triggering event promoting neurotoxic aggregation in motor neuron disease and, possibly, in other neurodegenerative conditions as well.
RESULTS
p190RhoGEF co-localizes with RNA-triggered NF-L protein aggregates but not with NF-L subunits which are assembled in filamentous arrays
To investigate the role of cognate RNA-binding proteins in RNA-triggered NF-L protein aggregation, we used our established cellular model in Neuro 2a cells (46) . Endogenous mouse NF-L and NF-M genes are methylated and not expressed in undifferentiated Neuro 2a cells (48) . This enabled transfection of NF-L to provide a single source of NF-L mRNA and NF-L protein for comparing the disposition of NF-L protein and expression of parent NF-L mRNA without interference from endogenous NF-L subunits. In this model, Neuro 2a cells are transfected with a GFP-tagged NF-L transgene with (pGFP/NF þ 3 0 -UTR) or without (pGFP/NF 2 3 0 -UTR) NF-L 3 0 -UTR sequence (Fig. 1A) . When expressed by a transgene lacking NF-L 3 0 -UTR sequence (pGFP/NF 2 3 0 -UTR), GFPtagged NF-L protein remains diffusely distributed throughout the cytoplasm of transfected cells (Fig. 1B) . When expressed by a transgene with NF-L 3 0 -UTR sequence (pGFP/NF þ 3 0 -UTR), the same GFP-tagged NF-L protein undergoes aggregation in the cytoplasm of transfected cells (Fig. 1E) .
At low-level expression of pGFP/NF þ 3 0 -UTR, NF-L subunits do not aggregate but assemble in filamentous arrays ( Fig. 1H ) with low-levels of endogenous NF-H in Neuro 2a cells (46) . Comparable levels of NF-L are present in lysates of cells transfected with pGFP/NF 2 3 0 -UTR or pGFP/ NF þ 3 0 -UTR (46) . RNA-triggered aggregation of NF-L protein maps to the proximal 45 nt of NF-L 3 0 -UTR (46) , the site of a destabilizing element and binding site of p190RhoGEF (47) . To probe whether p190RhoGEF is involved in RNA-triggered NF-L protein aggregation, we examined the distribution of endogenous p190RhoGEF in transfected cells. Whereas p190RhoGEF is diffusely distributed in untransfected Neuro 2a cells and in cells transfected with pGFP/NF 2 3 0 -UTR ( Fig. 1C and D) , p190RhoGEF aggregates in cells with high-level expression of pGFP/NF þ 3 0 -UTR ( Fig. 1F ) and co-localizes with aggregates of GFP-tagged NF-L protein (Fig. 1E -G) . When GFP-tagged NF-L is assembled with endogenous NF-H in filamentous arrays (Fig. 1H) , p190RhoGEF remains diffusely distributed in the cytoplasm (Fig. 1I ) and does not co-localize with NF-L in filamentous arrays (Fig. 1H -J Fig. S1G -I ). These findings indicate that RNA-triggered co-aggregation of p190RhoGEF with NF-L protein is not due to the GFP tag or restricted to a line of transfected neuronal cells.
RNA-triggered aggregation of NF-L protein is associated with loss of NF-L mRNA
Because p190RhoGEF binds to the destabilizing element in NF-L mRNA (47), we next examined the effects of coaggregation of p190RhoGEF with NF-L protein on levels of parent NF-L mRNA. In situ hybridizations were conducted on cells transfected with pGFP/NF þ 3 0 -UTR using antisense 3644 Human Molecular Genetics, 2005, Vol. 14, No. 23
( Fig. 2A -C) and sense ( Fig. 2D -F) probes to NF-L mRNA. Sense probes are non-reactive (Fig. 2E) , whereas antisense probes readily detect NF-L mRNA diffusely distributed in the cytoplasm of transfected Neuro 2a cells (Fig. 2B) . When individual cells are analyzed, prominent NF-L mRNA expression is only observed in cells expressing very low-tomedium-levels of NF-L protein (Fig. 2B, arrowheads) . Highlevel NF-L expression leads to large aggregates of NF-L 
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Lysates of the respective populations of cells were assessed by western blots for expression of NF-L protein (Fig. 2G) , by RT -PCR for expression of NF-L mRNA (Fig. 2H ) and aliquots were examined for GFP fluorescence in cytospin preparations. The presence of low-, medium-and high-level expressions of GFP-tagged NF-L protein in the respective populations of transfected cells was confirmed by western blot (Fig. 2G) . Examination of cytospin preparations showed that .95% of high-expressing cells contain large aggregates of NF-L protein, whereas most medium-expressing cells contain diffusely distributed or multiple small punctate forms of GFP-tagged NF-L protein (data not shown). Cells expressing low and medium levels of GFP-tagged NF-L protein show corresponding levels of NF-L mRNA (Fig. 2H) , whereas cells expressing high-level GFP-tagged NF-L protein contain low levels of NF-L mRNA ( We then examined the disposition of p190RhoGEF in the modified model of NF-L protein aggregation. In co-transfected cells, p190RhoGEF does not co-localize with filamentous forms of GFP-tagged NF-L protein including fine filamentous arrays ( Fig. 4A -C) or thin-to-thick filamentous bundles ( Fig. 4D -F ), but still co-localizes with aggregative forms of GFP-tagged NF-L protein (Fig. 4G -L) . In many cells where there is non-uniform density of protein aggregates (Fig. 4G ), p190RhoGEF co-localizes with the denser regions of NF-L protein aggregates, usually in the interior of the aggregates ( Fig. 4G -I , arrowheads). The findings indicate that co-expression of NF-M alters the distribution but does not prevent co-localization of p190RhoGEF in protein aggregates. However, the findings confirm our previous results that p190RhoGEF associates with aggregative forms but not with filamentous forms of NF-L.
Small interference RNA-induced silencing of p190RhoGEF expression increases NF assembly and reduces RNA-triggered aggregation of NF-L protein
The role of p190RhoGEF in RNA-triggered NF-L protein aggregation was further studied by silencing endogenous p190RhoGEF using small interference RNA (siRNA). Western blot shows that a 48 h transfection of Neuro 2a cells with siRNA D-01, D-02 or D-03 reduces p190RhoGEF by .80%, whereas siRNA D-04 reduces p190RhoGEF by 50%, compared with untreated and mock-transfected cells (Fig. 5A ). We then examined the effects of siRNA-induced down-regulation of p190RhoGEF on the disposition of NF-L when co-transfected with NF-M. We first examined co-transfections of NF-L and NF-M in Neuro 2a cells following siRNA-induced downregulation of p190RhoGEF. At 24 h, there is a marked increase of GFP-tagged NF-L in filamentous forms (Fig. 5C ) when compared with co-transfections in mock-treated cells (Fig. 5B) . Quantitation of these effects shows that downregulation of p190RhoGEF significantly reduces the percentage of cells bearing aggregative form and increases the percentage of cells containing filamentous forms of NF-L (Fig. 5E ). Similar levels of NF-L protein are observed in co-transfected cells with and without down-regulation of p190RhoGEF (Fig. 5D) . We further examined whether siRNA-induced down-regulation of p190RhoGEF could recover the disposition of NF-L subunits from aggregative to filamentous forms. Neuro 2a cells were first cotransfected with NF-L and NF-M for 24 h and then subjected to siRNA-induced down-regulation of p190RhoGEF. Interestingly, down-regulation of p190RhoGEF reduces the percentage of cells bearing aggregative form and increases the percentage of cells containing filamentous forms of NF-L (Fig. 5F ), very similar to the effects observed when cells are co-transfected following siRNA-induced down-regulation of p190RhoGEF (Fig. 5E ). The findings indicate that silencing of p190RhoGEF expression reduces aggregation and promotes assembly of NF-L subunits and suggest that p190RhoGEF may associate with NF-L in a manner that promotes aggregation and reduces assembly of NF-L subunits.
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The co-localization of p190RhoGEF and NF-L in protein aggregates and the ability of siRNA-induced down-regulation of p190RhoGEF to reduce aggregation of NF-L suggest that p190RhoGEF may associate with unassembled NF-L protein.
To explore this possibility, we prepared unassembled NF-L protein from Triton X-100 soluble supernatants of motor neuron-like NSC-34 cells and from mouse spinal cord homogenates, as described (49), and conducted co-precipitation assays on these fractions. Following incubation of supernatants with anti-p190RhoGEF, immunoprecipitates were immunoblotted with anti-NF-L. NF-L is present in immunocomplexes precipitated by agarose beads conjugated with Ã P , 0.05 compared with untreated or mock-treated and ÃÃ P , 0.01 compared with untreated or mock-treated. Scale bars, 10 mm.
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untranslated NF-L sequence in the 3 0 -UTR of a GFP reporter transgene (44) or a human G93A mutant SOD1 transgene. To explore these possibilities, we re-examined our transgenic model of NF-L RNA-triggered motor neuron degeneration (44) . We detect expression of the GFP reporter transgene in a population of motor neurons of lumbar spinal cord with condensed nuclei and cytoplasm (Fig. 6A, dark arrows) , but not in non-condensed motor neurons (Fig. 6A, white  arrows) . Similar groups of condensed motor neurons show enhanced anti-ubiquitin (Fig. 6B, dark arrows) , increased anti-p190RhoGEF (Fig. 6C, dark arrows) and loss of anti-NF-L (Fig. 6D, dark arrows) immunoreactivities when compared with non-condensed motor neurons (Figs. 6B -D, white  arrows) . In addition, strong anti-p190RhoGEF and anti-NF-L immunoreactivities occur in discrete punctate inclusions within the neuropil in the vicinity of motor neurons (Fig 6C  and D, arrowheads) . These inclusions are suggestive of dystrophic axons or dendrites in RNA-triggered motor neuron degeneration in mice and may occur in the neurites of degenerating motor neurons. Accumulations of ubiquitinated aggregates in neurites appear as early pathological changes in RNA-triggered degeneration of cultured motor neurons (45) .
We then examined p190RhoGEF immunoreactivity in the lumbar spinal cord of symptomatic (120 days) mice bearing a human G93A mutant SOD1 transgene. These sections show extensive vacuolization of neuropil surrounding motor neurons, as described (50). Strong anti-p190RhoGEF immunoreactivity is present in numerous small and large punctate inclusions (Fig. 7A, arrowheads) and linear profiles (Fig. 7A, arrows) within the vacuolated neuropil. Punctate inclusions (arrowheads) and linear profiles (arrows) in vacuolated neuropil also contain strong anti-NF-L (Fig. 7B) as well as anti-SOD1 immunoreactivities (Fig. 7C) . Focal aggregates of anti-ubiquitin immunoreactivity are also present in dystrophic neuritic processes (Fig. 7D, arrows) and in punctate inclusions (Fig. 7D , arrowheads) in symptomatic mice. Interestingly, we also observed loss of anti-NF-L immunoreactivities in perikarya of degenerating motor neurons (Fig. 7B, arrows with open arrowheads) .
To assess the role of punctate inclusions containing p190RhoGEF and NF-L in mutant SOD1 toxicity, we examined the lumbar spinal cord of presymptomatic (80 days) mice prior to appearance of a vacuolated neuropil. Multiple punctate inclusions containing p190RhoGEF are present in the neuropil surrounding motor neurons in the ventral horn of lumbar spinal cord from presymptomatic transgenic mice (Fig. 7E, arrowheads) . Similar punctate inclusions containing NF-L are very prominent in the neuropil in serial sections of lumbar spinal cord from the presymptomatic transgenic mice (Fig. 7F, arrowheads) . The findings suggest that punctate accumulations of p190RhoGEF and NF-L in neurites (axons or dendrites) of degenerating motor neurons may be an early pathological change in transgenic models of motor neuron disease due to overexpression of untranslated NF-L RNA (44) or a G93A mutant SOD1 transgene.
DISCUSSION
Our previous studies have shown that overexpression of untranslated NF-L RNA causes motor neuron degeneration in transgenic mice (44) , leads to accumulation of ubiquitinated aggregates in degenerating cultured motor neurons (45) and triggers aggregation of NF-L protein and co-aggregation of mutant SOD1 protein in neuronal cells (46) . We now show that RNA-triggered aggregation of NF-L protein is associated with co-aggregation of p190RhoGEF and that co-aggregation of p190RhoGEF and NF-L protein can lead to down-regulation of NF-L mRNA in neuronal cells. We also show that aggregates of p190RhoGEF and NF-L protein and loss of NF-L expression occur in degenerating motor neurons of different transgenic models of motor neuron disease expressing untranslated NF-L RNA or a G93A mutant SOD1 transgene. Loss of NF-L mRNA occurs in degenerating motor neurons of sporadic and familial ALS (51 -53) and is even more severe in neurons containing NF inclusions (53) . Loss of NF-L expression has also been reported in neurons-at-risk in other neurodegenerative diseases (54 -58) .
The salient feature of our study is the involvement of p190RhoGEF in a pathway linking loss of NF-L mRNA and aggregation of NF-L protein. However, neither the linkage nor the interactions of p190RhoGEF with NF-L RNA and with NF-L protein are straightforward. For example, crosslinking of p190RhoGEF to the destabilizing element in NF-L mRNA is altered by admixing p190RhoGEF with brain extracts (47) , suggesting that additional factors modify the RNA -protein interaction. Likewise, our ability to demonstrate interactions of p190RhoGEF and NF-L protein by coprecipitation but not by gel overlay assay suggests that the interactions of p190RhoGEF and NF-L protein may be indirect and dependent on additional factors. We therefore favor the view that p190RhoGEF interacts with NF-L mRNA in an RNAprotein complex and with unassembled NF-L protein in a multi-protein complex. Aggregation of NF-L protein and destabilization of NF-L mRNA result from altered interactions of p190RhoGEF in the respective complexes. A cartoon of our working hypothesis is shown in Figure 8 .
The model is consistent with observations that aggregation of NF-L protein and loss of NF-L mRNA are dependent on the presence and interactions of p190RhoGEF in an RNA -protein complex on NF-L mRNA and in a multi-protein complex on NF-L protein. For example, aggregation of NF-L protein in neuronal cells is dependent on the presence of NF-L 3 0 -UTR in the transgene (46), thereby enabling a complex containing p190RhoGEF to form on the destabilizing element in the transcript. Conversely, loss of NF-L mRNA is dependent on coaggregation of NF-L protein and p190RhoGEF protein which could reflect the formation of a complex containing p190RhoGEF on unassembled NF-L. Hence, loss of NF-L mRNA occurs following co-aggregation of p190RhoGEF and NF-L but not after siRNA-induced down-regulation of p190RhoGEF. In addition, loss of NF-L mRNA does not occur when NF-L co-aggregates with NF-M. In the latter instance, co-localization of NF-M with NF-L in protein aggregates may alter the interactions of p190RhoGEF in the multiprotein complex and the ability of the multi-protein complex to trigger down-regulation of NF-L mRNA.
Our working model also provides novel perspectives as to the nature of motor neuron degeneration resulting from overexpression of untranslated NF-L RNA in mice (44) (46) . It is also possible that the up-regulation of p190RhoGEF in degenerating motor neurons is a reactive change due to formation of complexes containing p190RhoGEF on NF-L protein or on NF-L mRNA. The presence of similar aggregates of NF-L and p190RhoGEF in neurites of motor neurons in presymptomatic mice expressing a G93A mutant SOD1 transgene suggests that these accumulations may also be instrumental in the aggregation of mutant SOD1 protein. Proximal neurites of motor neurons are sites where aggregates of G93A mutant SOD1 protein are reported to arise (50, 59) , raising the possibility that aggregation of mutant SOD1 protein may be promoted by aggregates of NF-L protein, as demonstrated in transfected neuronal cells (46) . It is also possible that aggregates of NF-L and mutant SOD1 protein have mutually synergistic effects (60) and that aggregates of mutant SOD1 may also enhance the aggregation of NF-L protein and p190RhoGEF and loss of NF-L expression. Hence, p190RhoGEF may be involved in the pathogenesis as well as loss of NF-L mRNA in mutant SOD1-induced motor neuron degeneration. Moreover, a lack of synergistic effects of NF-L and mutant SOD1 protein aggregates may help explain the ameliorating effects of deleting NF-L on the toxicity of a mutant SOD1 transgene (61) .
The prospective role of NFs in the pathogenesis of motor neuron disease derives from alterations of NF expression in mice that reproduce the pathology and phenotype of human disease. Interestingly, the disease state is not reproduced by deletion of one or more NF genes (62), but rather by overexpressing an NF transgene (63 -65) that alters NF subunit stoichiometry and leads to accumulation of NFs in motor neurons. Accumulations of NFs, however, are not necessarily neurotoxic because overexpression of a mutant NF-H with a lacZ replacement of C-terminal sequence leads to massive accumulations of NFs without the phenotype of disease (66) and without altering the toxicity of mutant SOD1 (67) . Instead, the neurotoxicity of NF transgenes appears to be 
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Human Molecular Genetics, 2005, Vol. 14, No. 23 associated with alterations of NF subunit stoichiometry that might alter NF-L assembly. Expression of a mutant NF-L reported to disrupt NF assembly causes severe motor neuron degeneration in transgenic mice (68) . Correction of subunit stoichiometry rescues motor impairment caused by overexpression of an NF-H transgene (69) . Further evidence that alterations in NF-L assembly cause motor neuron disease is provided by the assembly-disrupting mutations in NF-L that give rise to a distal motor and sensory axonal neuropathy in CMT2E (37 -39) . Although the pathological aggregates of NF-L are associated with defective axonal transport (38, 70) , it is unclear whether altered transport is directly related to aggregation of NF-L subunit. Defects in axonal transport are common phenomena in neurodegenerative diseases due to neurotoxic protein aggregates (71) and may account for the preferential susceptibility of distal axons in motor neuron disease (72, 73) . Recent genetic screens of ALS patients have identified risk factor mutations in peripherin that disrupt NF-L assembly in transfected SW13Vim -cells (74, 75) and may disrupt NF-L assembly in Our studies indicate that the putative complexes containing p190RhoGEF not only link NF-L protein aggregation with loss of NF-L expression but also regulate NF-L assembly. siRNA-induced silencing of p190RhoGEF reduces aggregation and increases assembly of NF-L and NF-M. It also promotes their re-assembly when siRNAs are added after cells have been co-transfected with NF-L and NF-M. Because the complex containing p190RhoGEF has the unique property of interacting with unassembled, but not with assembled NF-L, we propose that the complex acts as an interactive component that is only dissociated by assembly of NF-L with heterologous subunits. By preventing NF-L self-assembly, the p190RhoGEF-containing complex may help assure a heterologous composition of assembled NFs in vivo.
Interactions of the p190RhoGEF-containing complex with NF-L subunits promote aggregation of unassembled subunit and permit assembly with NF-M or NF-H. This is reminiscent of the obligate heteropolymer behavior of NF-L subunits when transfected in SW13Vim -cells (79, 80) . However, the obligate heteropolymer requirement of NF-L assembly in vivo contrasts with the ready self-assembly property of NF-L in vitro (81, 82) and in the yeast two-hybrid system (83) . This raises 
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Human Molecular Genetics, 2005, Vol. 14, No. 23 the question as to the factors or conditions that restrict self-assembly in vivo. The p190RhoGEF-containing complex may be a factor restricting self-assembly of NF-L in vivo.
Because large neurons express an abundance of all three NF subunits, the complex containing p190RhoGEF would not interfere in assembly of NF-L with NF-M and NF-H, but could serve as a gatekeeper of NF-L assembly, preventing self-assembly and providing a feedback mechanism to down-regulate NF-L mRNA in response to an excess or persistence of unassembled NF-L subunits in the cell. The pathway could also serve to regulate levels of NF-L mRNA expression in accordance with levels of NF-L assembly in the cell. Feedback regulation of NF-L expression is necessary for maintaining a steady-state level of NF metabolism and, in turn, for preserving the size and shape of the axonal cytoskeleton of large NF-rich neurons. The ability to co-precipitate low levels of p190RhoGEF and NF-L from detergent-soluble supernatants is consistent with the existence of a complex containing p190RhoGEF and NF-L protein in normal adult mouse spinal cord.
The possibility that complexes containing p190RhoGEF operate in feedback pathways linking NF-L expression and NF assembly provides additional perspectives as to the nature of pathological aggregates of NF-L and p190RhoGEF in motor neuron disease. First, it suggests that the multi-component complexes containing p190RhoGEF that interact with NF-L mRNA and NF-L protein are important for maintaining neuronal homeostasis and that alterations of these complexes can give rise to a pathological state. Hence, accumulations of NF-L and p190RhoGEF aggregates in degenerating motor neurons result from an alteration in a pathway intended to maintain neuronal homeostasis. Moreover, the upstream triggering events could arise from alteration of individual components within each complex or from their altered interactions in the complexes or with components in other pathways in the cell. Finally, the interactions of multi-component complexes could be influenced by specific neuronal microenvironments, thereby contributing to the vulnerabilities of different subsets of large NF-rich neurons-at-risk in neurodegenerative diseases.
It is noteworthy that p190RhoGEF is a highly interactive protein (84 -88) with potential activities in multiple neuronal pathways. The involvement of p190RhoGEF in aggregation of NF-L in motor neuron degeneration may be of particular interest in view of the causative role of alsin (89, 90) , especially its RhoGEF component (91) , and of senataxin (92) , another RNA-binding protein, in familial ALS. Finally, stabilization of NF-L mRNA may also be a pivotal upstream regulatory event that is not only linked to the disposition of NF-L protein but also regulated by glycolytic enzymes and is thereby associated with the high-energy requirements of large NF-rich neurons (93) .
MATERIALS AND METHODS

Expression vectors
Full-length NF-L coding region with and without 3 0 -UTR were amplified by PCR from a mouse brain cDNA library (Stratagene, La Jolla, CA, USA) and fused in-frame to the C-terminus of EGFP coding region in pEGFP/C2 expression vector (BD Biosciences Clontech, Palo Alto, CA, USA) to generate pGFP/NF þ 3 0 -UTR and pGFP/NF 2 3 0 -UTR transgenes (46) , as shown schematically in Figure 1A . NF-M was amplified by PCR from a mouse spinal cord cDNA library (Stratagene) and cloned into pHM6 (Roche Applied Sciences, Indianapolis, IN, USA). GFP-tagged NF-L and hemagglutinin (HA)-tagged NF-M proteins were expressed as 97 and 160 kDa proteins in transfected cells (Figs 2G and 3I) . The integrity of all DNA constructs was verified by DNA sequencing.
Neuronal cultures and transfection
Mouse Neuro 2a neuroblastoma and motor neuron-like NSC-34 cells (provided by Dr Neil Cashman, University of Toronto, Canada) were maintained in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA)with 10% fetal calf serum. Cells were transfected with FuGENE6 according to manufacturer's instructions (Roche Applied Sciences). Co-transfections were performed with 1:1 ratio of each expression vector unless otherwise specified. Cells were collected for western blots at 24 or 48 h following transfection.
Immunocytochemistry and confocal microscopy
Cells were fixed in 4% paraformaldehyde for 1 h at 48C or in acetone/methanol for 3 -5 min at room temperature and permeabilized in 0.5% Triton X-100. Fixed cells were incubated overnight at 48C with the following primary antibodies: goat polyclonal anti-NF-L (1:200 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA), goat polyclonal anti-NF-M (1:100 dilution, Santa Cruz Biotechnology) or rabbit polyclonal anti-p190RhoGEF antibody (1:100 dilution) (85) . Secondary antibody incubations were conducted with Alexa Fluorw 594 chicken anti-rabbit IgG or Alexa Fluor 594 donkey anti-goat IgG (Molecular Probes, Eugenes, OR, USA), and cover slips were mounted in VECTASHIELD mounting medium with DAPI (Vector Laboratories, Burlingame, CA, USA). GFP fluorescence, anti-NF-L, anti-NF-M and anti-p190RhoGEF immunofluorescence were visualized in DAPI-stained cells by multi-track sequential scanning using a Zeiss LSM510 META laser scanning confocal microscope.
In situ hybridization analysis
Neuro 2a cells were washed and fixed with freshly made 4% paraformaldehyde in DEPC-treated phosphate-buffered saline (PBS) for 1 h at 48C, then washed once with 50% formamide and 5 Â SSC, incubated in hybridization buffer (50% formamide, 5 Â SSC, 1 mg/ml yeast tRNA, 200 mg/ml heparin, 1 Â Denhardt's solution, 0.1% Tween-20, 0.1% Triton X-100 and 5 mM EDTA, pH 8.0) for 1 h at room temperature and then hybridized with 50 ng/ml sense or antisense NF-L oligonuclotide probe labeled by tetramethylrhodamine-5-dUTP using DIG oligonucleotide tailing kit 2nd generation (Roche Applied Sciences) in hybridization buffer at 378C overnight. Neuro 2a cells were then washed with 0.2 Â SSC and mounted in VECTASHIELD mounting medium with DAPI (Vector Laboratories). GFP fluorescence and red fluorescence for mRNA signals were visualized in DAPI-stained cells by were assessed by densitometric scanning and normalized to the respective dilution factors. Membranes were blocked overnight at 48C in TBST -milk (50 mM Tris -HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20, 5% non-fat milk powder) and incubated sequentially in primary andsecondary antibodies (anti-rabbit or anti-goat IgG conjugated with HRP) for 1 h at room temperature. Labeled proteins were detected using western blot chemiluminescence reagent (Roche Applied Sciences).
siRNA to p190RhoGEF
Four siRNA sequences to p190RhoGEF, D-01, D-02, D-03 and D-04, were designed and synthesized by Dharmacon (Lafayette, CO, USA). For siRNA transfection, Neuro 2a cells were plated into 12-well plates at 1 Â 10 5 cells/ml in antibiotic-free medium and incubated at 378C with 5% CO 2 overnight and then transfected with siRNAs using Liopectamine 2000 (Invitrogen) for 48 h according to manufacturer's instructions. To assess the effects of siRNA on endogenous p190RhoGEF expression, Neuro 2a cells were lysed on ice in lysis buffer containing 10 mM Tris -HCl, pH 7.0, 150 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA, 10% glycerol, 1 mM PMSF, mammalian protease inhibitor cocktail (Sigma) and 1% Triton X-100. Total lysates were centrifuged at 13 500g and supernatants were analyzed by western blot. To assess the effects of siRNA-induced silencing of p190RhoGEF on aggregation and assembly of NF-L subunits, Neuro 2a cells were co-transfected with GFP-tagged NF-L and HA-tagged NF-M transgenes using Lipofectamine 2000 (Invitrogen) at 48 h after transfections with p190RhoGEF siRNAs. At 24 h following co-transfection, Neuro 2a cells were fixed and mounted in VECTASHIELD mounting medium with DAPI (Vector Laboratories). The number of co-transfected cells with filamentous arrays and with aggregates was counted under the fluorescence microscopy and the percentages were calculated. Three independent observations were conducted on each preparation.
Light microscopic and immunohistochemistry
Transgenic mice bearing a human G93A mutant SOD1 were purchased from Jackson's Laboratory (Bar Harbor, MI, USA). Transgenic mice were anesthetized with CO 2 and cardiac perfused with 10 ml of PBS, followed by 20 ml of PBS containing 4% paraformaldehyde. Brains and spinal cords were excised and immersed overnight in 4% paraformaldehyde, washed in PBS, dehydrated and embedded in paraffin. Spinal cords were cut and positioned inparaffin blocks to obtain representative cross-sections from cervical to lumbar cord. Other spinal cord sections were obtained from transgenic mice expressing untranslated NF-L RNA (44) . Paraffin-embedded sections of spinal cord sections were deparaffined, rehydrated, antigen-retrieved in Antigen Unmasking Solution (Vector Laboratories) and then treated with 3% H 2 O 2 to block endogenous peroxidase. After incubation with normal rabbit serum (1:10 in PBS), the sections were incubated with goat polyclonal anti-NF-L antibody (1:100 dilution, Santa Cruz Biotechnology), rabbit polyclonal anti-p190RhoGEF antibody (1:100 dilution) (85), rabbit polyclonal anti-GFP antibody (1:200 dilution, Clontech) or rabbit polyclonal anti-ubiquitin (1:500 dilution, Santa Cruz Biotechnology) overnight at 48C, washed and then stained with VEC-TASTAIN Elite ABC Kit (Vector Laboratories). The immunoreactivity was revealed using DAB Substrate Kit for peroxidase (Vector Laboratories) and observed under light microscopy.
Co-immunoprecipitation assays
NSC-34 cells were lysed in cold lysis buffer [50 mM TrisHCl, pH 8.0, 150 mM NaCl, 1.5 mM MgCl 2 , 1% Triton X-100, 1 mM PMSF and mammalian protease inhibitor (Sigma)] and clarified by centrifugation at 13 500g for 10 min at 48C. Spinal cords from normal adult mice were homogenized in ice-cold homogenization buffer containing 10 mM Tris -HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and a cocktail of protease inhibitor (Sigma) using a Teflon-on-glass homogenizer and centrifuged at 13 500g for 15 min at 48C, as described by Nguyen et al. (49) . Supernatants from cell lysates or spinal cord homogenate were subjected to co-immunoprecipitation (94) . About 500 mg of total protein extracts were incubated overnight at 48C with unconjugated beads or agarose beads conjugated with antip190RhoGEF (85) . The beads were washed four times, boiled in SDS loading buffer and eluted proteins analyzed by western blot with anti-NF-L antibody (Santa Cruz Biotechnology).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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